AIS Healthcare has announced the acquisition of Hunt Valley PharmaLAB (“Hunt Valley”), a 503A compounding pharmacy focused on ophthalmology medications. Already the leading targeted drug delivery (TDD) and infusion care provider, AIS Healthcare will now be able to provide high-quality, custom ophthalmology prescriptions to patients across the country. Hunt Valley provides patient-specific medications for patients undergoing eye surgery or suffering from chronic and complex conditions, such as dry eye. Based in Hunt Valley, MD, the pharmacy currently serves more than 6,700 patients in 15 states. Using Hunt Valley’s existing pharmacy and the new state-of-the-art facility in Dallas, Texas, AIS Healthcare will produce ophthalmic medications for an expanded number of patients.
Read the full article: AIS Healthcare Acquires Ophthalmology Compounding Pharmacy Hunt Valley PharmaLAB //